Scholars Central

Conference abstractPublished 18 Jul 2019

Challenges in developing biosimilars

Authors: Subir K Basak

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Biopharmaceuticals are the new growth driver of the pharma industry. They are usually more difficult to develop via R&D, more expensive to produce and more challenging to navigate for regulatory approval and commercialize. The key challenges are finding the right talent, technology and investors who believe in the long-term vision of this field. The technology for biotechnology and biosimilar keeps changing and so do the regulations. It has often been the case when the company starts with technology X to develop products for the local market and some exports. Thereafter, the strategy changes to work on different markets. What are the implications of such changes? What role does government regulatory or policy place in biosimilars development? How does the regulatory strategy impact the effectiveness to develop the right products in a high quality and yet cost-effective manner? This requires huge upfront investment which can be challenging for small and mid-size companies to commit. Sometimes with small commitments, there are unrealistic expectations in terms of R&D or product quality. How much money does a company need for its biopharma strategy? Finding the right talent is difficult in emerging markets since the talent concentration is very high in developed markets and the ecosystem is well developed. Few emerging markets are breaking this barrier.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Pharmaceutica Analytica Acta.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutica Analytica Acta
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Subir K Basak”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels